These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33827451)

  • 1. Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study.
    Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
    BMC Gastroenterol; 2021 Apr; 21(1):153. PubMed ID: 33827451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study.
    Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
    Thorac Cancer; 2021 Jul; 12(14):2065-2071. PubMed ID: 34028200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study.
    Lin CY; Lien MY; Chen CC; Fang HY; Lin YS; Chen CK; Chen JX; Lu TY; Huang TM; Hsieh TC; Sun SS; Li CC; Chien CR
    BMC Gastroenterol; 2022 Aug; 22(1):381. PubMed ID: 35948871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
    Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
    Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography-staged esophageal squamous cell carcinoma after complete resection: A population-based cohort study.
    Fang HY; Lin YS; Chen CK; Chen JX; Lu TY; Huang TM; Hsieh TC; Kuo YC; Lin CY; Lien MY; Chen CC; Li CC; Chien CR
    Thorac Cancer; 2022 Jul; 13(13):1986-1993. PubMed ID: 35661426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy: A population-based propensity-score-matched analysis.
    Li CC; Chen CY; Chien CR
    Medicine (Baltimore); 2018 Jun; 97(22):e10928. PubMed ID: 29851829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia.
    Kuo YH; Chien YW; Chen PR; Feng CL; Li CC; Chien CR
    World J Surg Oncol; 2019 Dec; 17(1):222. PubMed ID: 31856840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.
    Liang JA; Tu CY; Hsia TC; Fang HY; Li CC; Chien CR
    Thorac Cancer; 2020 Sep; 11(9):2639-2649. PubMed ID: 32725779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
    Li CC; Fang HY; Lin CY; Shen WC; Chien CR
    Anticancer Res; 2019 Jan; 39(1):511-517. PubMed ID: 30591503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
    Chen CY; Li CC; Chien CR
    World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
    Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
    Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
    Chen CY; Li CC; Chien CR
    Radiother Oncol; 2016 Jul; 120(1):136-9. PubMed ID: 27207358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
    Fan C; Wang X; Zheng X; Sun Y; Ye K; Jiang Y; Liu X; Xu W; Liu Y; Yang Y; Liu J; Jiang Q; He C; Wu X; Nie X; Zhang J; Tan B; Wang W; Zhang Y; Feng Z; Yang C; Lu Y; Liu H; Chen X; Xu J; Liu F; Zheng X; Wang J; Wu S; Chen G; Zhang Y; Jin L; Ge H
    BMC Cancer; 2024 Mar; 24(1):321. PubMed ID: 38454345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis.
    Li CC; Chen CY; Chien CR
    Oncotarget; 2016 Nov; 7(44):71548-71555. PubMed ID: 27689398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma.
    Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
    In Vivo; 2021; 35(2):1133-1139. PubMed ID: 33622911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
    Anticancer Res; 2020 Mar; 40(3):1771-1778. PubMed ID: 32132086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
    Ren XJ; Wang L; Han C; Liu LL
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study.
    Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Lin YC; Chien CR
    Discov Oncol; 2022 Nov; 13(1):130. PubMed ID: 36434304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.